Anokion

Anokion is a clinical-stage biotechnology company focused on prevalent and rare autoimmune diseases, including celiac disease, multiple sclerosis, and type 1 diabetes. Its approach leverages the company's immune-based platform, which targets natural pathways in the liver to restore immune tolerance and address autoimmune conditions.